Previous close | 1.4200 |
Open | 1.4100 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 1.4100 - 1.4290 |
52-week range | 0.5850 - 3.5000 |
Volume | |
Avg. volume | 16,715 |
Market cap | 28.586M |
Beta (5Y monthly) | 1.75 |
PE ratio (TTM) | 10.99 |
EPS (TTM) | 0.1300 |
Earnings date | 14 Jun 2022 - 20 Jun 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.00 |
Ken D'Entremont, Chief Executive Officer, Medexus Pharmaceuticals (Medexus) (TSX: MDP) shares his Company's story in an interview with TMX Group.